Kazia Therapeutics (KZIA) Stock Price, Quote, News & History | Benzinga

Kazia Therapeutics Ltd (KZIA) Stock Price, Quote, News & History

KZIANASDAQ

Trade with Public

Trade with Public

$11.40

0.454.11%

At close: Jun 4, 5:00 PM EST

$11.40

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Events Options Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$11.10

Close

$11.40

Volume / Avg.

163.98K / 212.47K

Day Range

$10.98 - $12.04

52 Wk Range

3.75 - 17.40

Market Cap

$130.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

3.18%

Days to Cover

2.05

Recent Kazia Therapeutics Ltd News

Kazia Therapeutics Reports Positive Early Responses In Aggressive Breast Cancer Trial

Kazia Therapeutics shared clinical update on Phase 1b study of paxalisib for late-stage metastatic TNBC. Encouraging responses observed.

Vandana Singh

What's Going On With Cancer Firm Kazia Therapeutics

Kazia announced a private placement of $50 million in equity securities. Proceeds will fund clinical development and extend cash runway.

Vandana Singh

What Sparked Kazia Therapeutics' Over 51% After-Hours Surge?

Kazia Therapeutics jumped 51.74% in after-hours trading Tuesday after reporting a rare immune-complete response in a patient.

Mohd Haider

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-14.40M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

81.56M

Free Cash Flow (TTM)

-14.40M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

67.17M

Analyst Trends and Forecast

1

Dec 25

1

Jan

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$93.72M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

811.88

PB Ratio (TTM)

3.76

Earnings Yield % (TTM)

-69.55%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.91

Company Debt

Total Debt

$98.81K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$69.46M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$11.10

Close

$11.40

Volume / Avg.

163.98K / 212.47K

Day Range

$10.98 - $12.04

52 Wk Range

3.75 - 17.40

Market Cap

$130.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

3.18%

Days to Cover

2.05

About

Sector

Health Care

Industry

Biotechnology

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Kazia Therapeutics (KZIA) stock?

A

You can purchase shares of Kazia Therapeutics (NASDAQ:KZIA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kazia Therapeutics (KZIA) competitors?

A

There are no as such competitors for Kazia Therapeutics.

Q

What is the forecast, or price target, for Kazia Therapeutics (KZIA) stock?

A

Kazia Therapeutics has a consensus price target of $19.50.

Q

What is the current price for Kazia Therapeutics (KZIA)?

A

The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $11.4 last updated June 4, 2026 at 4:00 PM EDT.

Q

Does Kazia Therapeutics (KZIA) pay a dividend?

A

There are no upcoming dividends for Kazia Therapeutics.

Q

When is Kazia Therapeutics (NASDAQ:KZIA) reporting earnings?

A

Kazia Therapeutics does not have any upcoming earnings scheduled.

Q

Is Kazia Therapeutics (KZIA) going to split?

A

There is no upcoming split for Kazia Therapeutics.

Q

What sector and industry does Kazia Therapeutics (KZIA) operate in?

A

Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.